The 14th WRIB Virtual (Workshop on Recent Issues in Bioanalysis) will be built on the success of the previous meetings, especially the 13th WRIB where over 1000 professionals representing pharmaceutical/biopharmaceutical companies, CROs and multiple regulatory agencies convened to discuss current topics of interest in Bioanalysis, Biomarkers, Immunogenicity and Gene Therapy. High Quality, better compliance to regulations and scientific excellence are always the foundations of this workshop.
CMIC’s laboratory offers bioanalysis for non-clinical and clinical projects, both GLP and non-GLP within a state-of-the-art facility that has the capacity to accommodate quick turnaround for high-volume projects. CMIC’s skilled researchers provide deep expertise in small and large molecule bioanalysis, biomarker services and oligonucleotide bioanalysis expertise. Learn more: https://en.cmicgroup.com/locations/chicago-il-usa/